Perceived stigma among patients receiving antiretroviral treatment: A prospective randomised trial comparing an m-DOT strategy with standard-of- care in Kenya

Sahara J

Volumn 7, Issue 2, 2010, Pages 62-70

  Kaai, Susan ^a   Bullock, Sandra ^a   Sarna, Avina ^b   Geibel, Scott ^b   Rutenberg, Naomi ^b   Chersich, Matthew ^c   Luchters, Stanley ^d   Munyao, Paul ^e   Mandaliya, Kishorchandra ^e   Temmerman, Marleen ^f,g  

^a UNIVERSITY OF WATERLOO   (Canada)

^b Population Council   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d GHENT UNIVERSITY   (Belgium)

^e ICAP ^*  (Kenya)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g International Centre for Reproductive Health Kenya   (Kenya)

Author keywords

Africa; Attitudes; Directly observed therapy; HIV AIDS; Perceived stigma

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; KENYA; MALE; METHODOLOGY; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PERCEPTION; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANTI-HIV AGENTS; DIRECTLY OBSERVED THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV; HIV INFECTIONS; HUMANS; KENYA; MALE; MEDICATION ADHERENCE; OUTPATIENT CLINICS, HOSPITAL; PERCEPTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; SELF ADMINISTRATION; STEREOTYPING;

EID: 77957894376     PISSN: 17290376     EISSN: 18134424     Source Type: Journal    
DOI: 10.1080/17290376.2010.9724958     Document Type: Article

References (67)

1. Abusabha, R., & Woelfel, M. L. (2003). Qualitative vs quantitative methods: Two opposites that make a perfect match. Journal of the American Dietetic Association, 103 (5), 566-569.
2. Altice, F. L., Maru, D. S., Bruce, D. R., Springer, S. A., & Friedland, G. H. (2007). Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial. Clinical Infectious Diseases, 45(6), 770-778.
3. Altice, F. L., Mezger, J., Hodges, J., Bruce, R., Marinovich, A., Walton, M. et al. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clinical Infectious Diseases, 38, S376-S387.
4. Bangsberg, D. R., Acosta, E. P., Gupta, R., Guzman, D., Riley, E. D., Harrigan, R. P. et al. (2006). Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS, 20(2), 223-231.
5. Bangsberg, D. R., Ware, N., & Simoni, J. M. (2006). Adherence without access to antiretroviral therapy in sub-Saharan Africa? AIDS, 20(1), 140-141.
6. Beck, A., & Mendelson, M. (1961). Becks Depression Inventory (BDI). Archives of General Psychiatry, 4, 561-571.
7. Berger, B. E., Ferrans, C., & Lashley, F. (2001). Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Research in Nursing and Health, 24, 518-529.
8. Carpenter, C., Cooper, D., & Fischl, M. (2000). Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel. Journal of the American Medical Association, 283, 381-390.
9. Chen, S., Yu, J., Harries, A., Bong, C., Kolola-Dzimadzi, R., Tok, R. et al. (2008). Increased mortality of male adults with AIDS related to poor adherence to antiretroviral therapy in Malawi Tropical Medicine & International Health, 13(4), 513-519.
10. Christopher, G. (2006). Commentary on meta-analysis of randomized controlled trials for HIV treatment adherence interventions: Research directions and implications for practice. Journal of Acquired Immune Deficiency Syndromes, 43(S1), S36-S40.
11. Conway, B. (2007). The role of adherence to antiretroviral therapy in the management of HIV infection. Journal of Acquired Immune Deficiency Syndromes, 45(1), S14-S18.
12. Diabate, S., Alary, M., & Koffi, C. (2007). Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cote d’Ivoire. AIDS, 21(13), 1799-1803.
13. Dlamini, P. S., Wantland, D., Makoae, L. N., Chirwa, M., Kohi, T. W., Greeff, M. et al. (2009). HIV stigma and missed medications in HIV-positive people in five African countries. AIDS Patient Care and STDs, 23(5), 377-387.
14. Farmer, P., Leandre, F., Mukherjee, J., Gupta, R., Tarter, L., & Kim, J. Y. (2001). Community-based treatment of advanced HIV disease: introducing DOTHAART (directly observed therapy with highly active antiretroviral therapy). Bulletin of the World Health Organisation, 79(12), 1145-1152.
15. Gill, C. J., Hamer, D. H., Simon, J. L., Thea, D. M., & Sabin, L. L. (2005). No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS, 19(12), 1243-1249.
16. Goffman, E. (Ed.). (1963). Stigma: Notes on the management of spoiled identity. New York: Simon & Schuster.
17. Greeff, M., & Phetlhu, R. D. (2007). The meaning and effect of HIV/AIDS stigma for people living with AIDS and nurses involved in their care in the North West Province, South Africa. Curationis, 30(2), 12-23.
18. Hardon, A., Akurut, D., Comoro, C., Ekezie, C., Irunde, H., Gerrits, T. et al. (2007). Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care, 19(5), 658-665.
19. Herek, G. M., Capitanio, J. P., & Widaman, K. (2002). HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991-1999. American Journal of Public Health, 92, 371-377.
20. Ickovics, J., & Meade, C. (2002). Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care, 14, 309-318.
21. Katamba, A., Neuhauser, D., Smyth, K., Adatu, F., Katabira, E., & Whalen, C. (2005). Patients perceived stigma associated with community-based directly observed therapy of tuberculosis in Uganda. East African Medical Journal, 82(7), 337-342.
22. Kip, E., Ehlers, V. J., & van der Wal, D. M. (2009). Patients’ adherence to antiretroviral therapy in Botswana. Journal of Nursing Scholarship, 41(2), 149-157.
23. Liechty, C. A., & Bangsberg, D. R. (2003). Doubts about DOT: antiretroviral therapy for resource-poor countries. AIDS, 17, 1383-1387.
24. Macalino, G., Hogan, J., Mitty, J., Bazerman, L., Delong, A., Loewenthal, H. et al. (2007). A randomised clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS, 21(11), 1473-1477.
25. Makoae, L. N., Greeff, M., Phetlhu, R. D., Uys, L. R., Naidoo, J. R., Kohi, T. W. et al. (2008). Coping with HIV-related stigma in five African countries. Journal of the Association of Nurses in AIDS Care, 19(2), 137-146.
26. Malangu, N. (2008). Self-reported adverse effects as barriers to adherence to antiretroviral therapy in HIV-infected patients in Pretoria. South African Family Practice, 50(5), 49-49b.
27. Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P. et al. (2006). Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and faciliators. Plos Medicine, 3(11), e438.
28. Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S. et al. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America Journal of the American Medical Association, 296, 679-690.
29. Mitchell, C., Freels, S., Creticos, C., Oltean, A., & Douglas, R. (2007). Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counselling. AIDS Care, 19(4), 561-564.
30. Mitty, J., Stone, V., Sands, M., Macalino, G., & Flanigan, T. (2002). Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clinical Infectious Diseases, 34, 984-990.
31. Mukherjee, J., Ivers, L., Leandre, F., Farmer, P., & Behforouz, H. (2006). Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl 1), S123-126.
32. Munoz, M., Finnegan, K., Zeladita, J., Caldas, A., Sanchez, E., Callacna, M. et al. (in press). Community-based DOT-HAART accompaniment in an urban resource-poor setting. AIDS Behaviour.
33. Murray, L. K., Semrau, K., McCurley, E., Thea, D. M., Scott, N., Mwiya, M. et al. (2009). Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care, 21(1), 78-86.
34. Nachega, J., Knowlton, A., Deluca, A., Schoeman, J. H., Watkinson, L., Efron, A. et al. (2006). Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl 1), S127-133.
35. Nyblade, L. (2006). Measuring HIV stigma: Existing knowledge and gaps. Psychology Health & Medicine, 11(3), 335-345.
36. Nyblade, L., & MacQuarrie, K. (2006). Can we measure HIV/AIDS-related stigma and discrimination? Current knowledge about quantifying stigma in developing countries Washington, DC United States Agency for International Development.
37. Page-Shipp, L. S., Charalambous, S., Roux, S., Dias, B., Sefuti, C., Churchyard, G. J. et al. (2007). Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa. Sexually Transmitted Infections, 83, 383-386.
38. Pearson, C. R., Micek, M., Simoni, J. M., Hoff, P. D., Matediana, E., Martin, D. P. et al. (2007). Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. Journal of Acquired Immune Deficiency Syndromes, 46(2), 238-244.
39. Pearson, C. R., Micek, M., Simoni, J. M., Matediana, E., Martin, D. P., & Gloyd, S. (2006). Modified Directly Observed Therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique: Development and implemetation. Journal of Acquired Immune Deficiency Syndromes, 43(S1), S134-S141.
40. Pearson, C. R., Micek, M. A., Pfeiffer, J., Montoya, P., Matediane, E., Jonasse, T. et al. (in press). One year after ART initiation: Psychosocial factors associated with stigma among HIV positive Mozambicans. AIDS and Behavior.
41. Peltzer, K., Mosala, T., Shisana, O., Nqueko, A., & Mngqundaniso, N. (2007). Barriers to Prevention of HIV transmission from mother to child (PMTCT) in a resource poor setting in the Eastern Cape, South Africa. African Journal of Reproductive Health, 11(1), 57-66.
42. PEPFAR (2008). 2008 Country Profile: Kenya. Retrieved March 20, 2008, from http://www. pepfar. gov
43. Plummer, M., Mshana, G., Wamoyi, J., Shigongo, Z., Hayes, R., Ross, D. et al. (2006). The man who believed he had AIDS was cured: AIDS and sexuallytransmitted infection treatment-seeking behaviour in rural Mwanza, Tanzania. AIDS Care, 18, 4060-4066.
44. Pulerwitz, J., Michaelis, A., Lippman, S., Chinaglia, M., & Diaz, J. (2008). HIVrelated stigma, service utilization, and status disclosure among truck drivers crossing the southern borders of Brazil. AIDS Care, 20(2), 198-204.
45. Ramadhani, H., Thielman, N., Landman, K., Ndosi, E., Gao, F., Kirchherr, J. et al. (2007). Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clinical Infectious Diseases, 45(11), 1492-1498.
46. Rao, D., Kekwaletswe, T., Hosek, S., Martinez, J., & Rodriguez, F. (2007). Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care, 19(1), 28-33.
47. Remien, R., Stirratt, M., Dolezal, C., Dognin, J., Wagner, G., Carballo-Diequez, A. et al. (2005). Couple-focused support to improve HIV medication adherence: a randomised controlled trial. AIDS, 19(8), 807-814.
48. Roura, M., Urassa, M., Busza, J., Mbata, D., Wringe, A., & Zaba, B. (2009). Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV-testing. Early evidence from rural Tanzania. Sexually Transmitted Infections, 85(4), 308-312.
49. Sabin, L., DeSilva, M., Hamer, D., Xu, K., Zhang, J., Li, T. et al. (in press). Using Electronic Drug Monitor feedback to improve adherence to antiretroviral therapy among HIV positive patients in China. AIDS Behaviour.
50. Safren, S., Hendriksen, E., Desousa, N., Boswell, S., & Mayer, K. (2003). Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care, 15(6), 787-793.
51. Safren, S., Otto, M., Worth, J., Salomon, E., Johnson, W., Mayer, K., et al. (2001). Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behaviour Research and Therapy, 39(10), 1151-1162.
52. Samet, J., Horton, N., Meli, S., Dukes, K., Tripp, T., Sullivan, L. et al. (2005). A randomised controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antiviral Therapy, 10(1), 83-93.
53. Sampaio-Sa, M., Page-Shafer, K., Bangsberg, D., Evans, J., Dourado, M., Teixeira, C. et al. (2008). 100% Adherence study: Educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behaviour, 12(Suppl 1), S54-62.
54. Santos, C. Q., Adeyemi, O., & Tenorio, A. (2006). Attitudes toward directly administered antiretroviral therapy (DAART) among HIV-positive inpatients in an inner city public hospital. AIDS Care, 18(7), 808-811.
55. Sarna, A., Luchters, S., Geibel, S., Chersich, M., Munyao, P., Kaai, S. et al. (2008). Short-and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: A randomized trial. Journal of Acquired Immune Deficiency Syndromes, 48(5), 611-619.
56. Sayles, J. N., Wong, M. D., Kinsler, J. J., Martins, D., & Cunningham, W. E. (2009). The association of stigma and self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. Journal of General Internal Medicine, 24(10), 1101-1108.
57. Simoni, J., Amico, K., Pearson, C., & Malow, R. (2008). Strategies for promoting adherence to antiretroviral therapy: A review of the literature. Current Infectious Disease Report, 10(6), 515-521.
58. Smith, S., Rublein, J., Marcus, C., Brock, T., & Chesney, M. (2003). A medication self-management program to improve adherence to HIV therapy regimens. Patient Education and Counseling, 50(2), 187-199.
59. Thorsen, V. C., Sundby, J., & Martinson, F. (2008). Potential initiators of HIVrelated stigmatisation: Ethical and programmatic challenges of PMTCT programs (Vol. 8). Oxford: Blackwell Publishing Ltd.
60. Tuldra, A., Fumaz, C., Ferrer, M., Bayés, R., Arnó, A., Balagué, M. et al. (2000). Prospective randomised two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 25(3), 221-228.
61. UNAIDS (2007). Reducing HIV stigma and discrimination: a critical part of national AIDS programmes. Retrieved 22 December, 2008, from http://data. unaids. org/pub/Report/2008/jc1420_stigma_discr_en. pdf
62. UNAIDS & WHO (2008). Epidemiological fact sheet on HIV and AIDS: 2008 update, Kenya. Geneva: UNAIDS and WHO.
63. Wakabi, W. (2008). Low ART adherence in Africa. The Lancet Infectious Diseases, 8(2), 94.
64. Weber, R., Christen, L., Christen, S., Tschopp, S., Znoj, H., Schneider, C. et al. (2004). Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antiviral Therapy, 9(1), 85-95.
65. Weidle, P., Wamai, N., Solberg, P., Liechty, C., Sendagala, S., Were, W. et al. (2006). Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet, 368(9547), 1587-1594.
66. Wolfe, W., Weiser, S., Bangsberg, D., Thior, I., Makhema, J., Dickinson, D. et al. (2006). Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care, 18(8), 931-933.
67. Wong, I., Lawrence, N., Struthers, H., McIntyre, J., & Friedland, G. (2006). Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa. Journal of Acquired Immune Deficiency Syndromes, 43(Suppl 1), S142-148.